General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes - Episode Artwork
Education

General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes

This episode discusses the findings of a recent study comparing general versus non-general anesthesia in patients undergoing endovascular thrombectomy for large core strokes. Despite previous beliefs,...

General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes
General vs Nongeneral Anesthesia for EVT in Patients With Large Core Strokes
Education • 0:00 / 0:00

Interactive Transcript

spk_0 This is José Merino, Editor in Chief of the Neurology Family of journals.
spk_0 The neurology podcast provides practical information to neurologists and other clinicians to help
spk_0 them provide better care for their patients.
spk_0 Thanks for listening and have a great week.
spk_0 Hello everyone, this is Andy Sutherland from the University of Virginia and I'm very
spk_0 excited to be speaking with my friend and colleague, Emre Sarage, who is the George M. Humphrey
spk_0 II Chair and Professor of Neurology at Case Western Reserve School of Medicine and
spk_0 Director of the Comprehensive Stroke Center at University Hospitals Cleveland Medical
spk_0 Center.
spk_0 For this week's neurology podcast, we're going to be discussing an article recently published
spk_0 in the journal titled General Versus Non-Generally Anesthesia for Endovascular thrombectomy
spk_0 in patients with large, core strokes.
spk_0 I was pre-specified secondary analysis of the select two trial.
spk_0 The select two trial was a prospective randomized trial that should benefit of endovascular thrombectomy
spk_0 in patients with large, core, schema strokes defined by aspect score of three to five on non-contrast
spk_0 head CT or an scheme core greater than or equal to 50 milliliters on CT perfusion study.
spk_0 Primary trial results were published in New England Journal in 2023 and today we're going
spk_0 to be discussing the results of this pre-specified analysis comparing patients who received
spk_0 a general versus non-general anesthesia in the trial.
spk_0 So, Amru, always great to have you on the podcast.
spk_0 Thanks for joining us.
spk_0 Thank you so much, Andy.
spk_0 It's a pleasure to be with you.
spk_0 Fantastic for our audience who may not keep up with this literature day to day in the realm
spk_0 of vascular neurology, acute stroke treatment.
spk_0 There have been numerous prior studies, meta-analyses of clinical trials that look at this sort
spk_0 of question of method of anesthesia in patients undergoing endovascular therapy for large,
spk_0 muscle occlusion stroke.
spk_0 One might ask, why is it important to readdress this in the select two randomized trial of patients
spk_0 with large, schema strokes, and specifically those with large, schema cores prior to the
spk_0 procedure?
spk_0 What is the relevance that led you and your team to want to pre-specify this as an important
spk_0 analysis?
spk_0 We are all approaching and charted territory until two or three years ago.
spk_0 It was for long believe that patients with large, schema core, those with low aspects
spk_0 early schema changes on the CAT scan aspects of 5 or less and just in brief the aspect is
spk_0 a major for good imaging profile or poor imaging profile, small core or large core in patients
spk_0 presenting with large, muscle occlusion.
spk_0 The prior trials showed benefit in small core excluded patients largely with aspects of
spk_0 5 or less and the core is measured on the perfusion images, those were areas that studied
spk_0 in research before and showed that patients who have regional, surploplethtflow less than
spk_0 30% as compared to a normal territory would have irreversible schema changes when you
spk_0 follow them on MRI at 72 hours.
spk_0 So those patients were excluded from prior trials or excluded from our practice largely.
spk_0 They were not part of guidelines, they were not part of practice guidelines at the different
spk_0 facilities because of inherited beliefs that they will not benefit.
spk_0 Rightfully the risk and benefit for a school is not well established because you have patients
spk_0 with large horse.
spk_0 Unlikely they will do as a natural history but also the potential benefit is not high
spk_0 because they have large skirts just having any large am I, very large subarachnoid
spk_0 hemorrhage.
spk_0 Prognosis is not good and the risk of hemorrhage transformation is high because you are
spk_0 reperfusing large area of them far.
spk_0 So now as we studied those in this elective trial and showed benefit of thrombectomy
spk_0 in this population as other 5 trials, randomized trials across the world reported benefit, the
spk_0 tension trial in Germany and Europe and Canada, the angel aspects in China, the rescue
spk_0 jet band limit in Japan, the last day trial in France and finally the Tesla trial which
spk_0 also showed either benefit in 5 trials or same direction with their protocol benefit in
spk_0 Tesla.
spk_0 Now those patients became part of the practice.
spk_0 They are being treated guidelines, been changed and the Australian guidelines been changed.
spk_0 The American Heart Association hopefully soon as as far as I know this is in advanced stages.
spk_0 This has been guidelines included these patients with aspects of 3 to 5, 0 to 24 hours.
spk_0 So when these become part of our practice we need to know how to approach these patients
spk_0 and anesthesia is one of the important goals that is associated with the procedure should
spk_0 I put the patient under general anesthesia or should I treat them with local or conscious
spk_0 sedation.
spk_0 That's the first part, the second part, while we showed benefit in this population we
spk_0 and others, the outcomes remained not as good as we want them.
spk_0 By nature these patients have very large strokes, you are not expecting the 60-70%
spk_0 independence rate or modified rankings, kilo-zero to 2 at 90 days.
spk_0 We observe somewhere around 20% rate but it's better than medical management of around
spk_0 7%.
spk_0 We observed 40% independence mobility in the amount of 3 which is excellent outcome.
spk_0 40% of patients with very large infarms being able to walk independently at 90 days as
spk_0 compared to doubling this in medical management.
spk_0 But we want to optimize these outcomes.
spk_0 We want this 40% to become 50 and 60.
spk_0 We want this 20% with the independent independence to be 30 and 40%.
spk_0 So it's these and similarly variables.
spk_0 The anesthesia, the blood pressure, be it at junk to therapies and reducing the edema
spk_0 being hemicraniactomy or being devices in different procedure approaches.
spk_0 These are the and silery variables that would help us optimizing the outcomes.
spk_0 That's why we thought this would be an important question to should lie down.
spk_0 And that makes complete sense, not only as you point out where these patients more or
spk_0 less excluded from prior trials so it's hard to extrapolate anything from how they would
spk_0 do based on our prior trial experience.
spk_0 There are legitimate biological, physiologic reasons why people with large schemes,
spk_0 coars large strokes would respond differently to different methods of anesthesia, may have
spk_0 different degrees of variability in their vital sign management and so forth both during
spk_0 and after the procedure.
spk_0 So naturally it is a very important question to readdress.
spk_0 Getting right to it, what were the main findings from this substudy that you all recently
spk_0 published?
spk_0 We asked the question, would patients with constestation or with general anesthesia have
spk_0 better association with clinical outcomes after thrombectomy.
spk_0 So this is only in the thrombectomy of a relation not in the medical management population
spk_0 when compared to each other on the 90 day outcome.
spk_0 And overall we found no difference.
spk_0 There was no difference in the modified rank and scale which is the function of an outcome
spk_0 at 90 days and we looked at one year because we have one year in and select two, no difference
spk_0 in independent emulation between general anesthesia and constestation.
spk_0 As you may imagine patients who receive general anesthesia take longer time to start the procedures
spk_0 of thromb randomization to doing the growing puncture.
spk_0 It was longer and was statistically significant but it was not associated with worse outcome.
spk_0 There was no difference in infarct volume and we limited the population to only the patients
spk_0 who got successful reperfusion, Antiqui to be more and there was no difference and we
spk_0 tried to look at interaction with the collateral status, stroke severity, the aspect score,
spk_0 there was no interaction.
spk_0 And going back the reason why we would think that one would be different than the others
spk_0 and I would say I was one of the people who thought that especially in this population
spk_0 patients with constestation will do better.
spk_0 These are large pore patients and you are worried that by doing general anesthesia the blood
spk_0 pressure will drop and you will lose collaterals and you will make what's already a large
spk_0 and far at large so the patients will end up doing worse.
spk_0 That's the hypothesis when we asked the question and actually to be fair while we did not
spk_0 specify constestation versus general anesthesia in the protocol we recommend that the size
spk_0 would do constestation and because it's not mandatory the size went on and did what they
spk_0 did and that would be my message to people in practice of throrours we ended up with 60%
spk_0 of the patients received in general anesthesia.
spk_0 So people did what they wanted to do and they perked to be right because there was no association
spk_0 between the type of anesthesia and the outcome.
spk_0 And you bring up a good point there.
spk_0 It does allow some flexibility and practice in folks who really work in this one way or
spk_0 the other and I agree with you it is a ought to probably lean towards your hypothesis leading
spk_0 up to the results of the study but it wasn't randomized.
spk_0 People did do what they wanted to do and so there's some inherent selection bias in that.
spk_0 How do you think these results will affect current practice, have they affected your own practice.
spk_0 And then what are some of those key limitations that we should keep in mind as we're interpreting
spk_0 the results of the substudy?
spk_0 Sure.
spk_0 As you mentioned we did not randomized and that on that anesthesia type.
spk_0 There were trials randomized on that anesthesia type back a few years ago that believe
spk_0 it can was that constestation or result in better outcome.
spk_0 It started with subanalyses from the Hermes showing better outcomes with constestation or
spk_0 local anesthesia as compared to general anesthesia.
spk_0 Then the randomized trials, the CS10 and stroke showed no difference.
spk_0 The Goliath and individual patient data metane analysis of four anesthesia general versus non-general
spk_0 showed better outcome with general anesthesia.
spk_0 From the paper that we published from, select and extend IA in a neurology a few years ago,
spk_0 a general anesthesia was associated with worse outcome, higher neurological worsening and
spk_0 worse effect in colatolous and that's why we had both his eyes and that's why we recommended
spk_0 and select to that patient that people do conscious sedation.
spk_0 Why the results are different?
spk_0 This is a major point that people should take into their practice, should take into their research.
spk_0 There is a difference between causation and association.
spk_0 A lot of times and we saw this over and over in blood pressure management.
spk_0 You come and do a subanalysis of what a prospective study in that patient with lower blood pressure
spk_0 ended up doing worse or better.
spk_0 That's and then you come and say lower blood pressure resulted in improved out.
spk_0 It is association. It is not causal relationship and that's why the trials that did intensive
spk_0 blood pressure management actually showed that patients do worse with intensive blood pressure
spk_0 management. It's the same concept when it comes to this.
spk_0 What we are learning and what we learned that the effect of endovascular thrombectomy and
spk_0 the perfusion is pretty strong and overcomes a lot of the ancillary variables around it.
spk_0 Of course we try to optimize everything but optimization does not always mean this way or the
spk_0 other. It might be your way that you do it best for the patients. If you are doing general
spk_0 anesthesia and you keep the patients not moving and your complications rate with pneumonia and other
spk_0 things are not high and you don't drop the blood pressure during the procedure then go ahead and do it.
spk_0 If you do conscious sedation better and you say my dissections rates are not too high and
spk_0 I'm not going to have complications then go ahead and do it. That is actually help because people don't
spk_0 need to change their protocol and say well for 15 years I have been doing conscious sedation and
spk_0 now you're coming and telling me to go ahead and do general anesthesia of rarsers. Not at all.
spk_0 As long as you and your team are comfortable with the procedure there was no difference in this
spk_0 specific variable when it comes to outcomes. When it comes to limitations and why I want people to
spk_0 when they read or when they see something say I'm not sure I agree with this. Of course this is
spk_0 non-randomized. I have news for you. I highly doubt that you will ever have this question being
spk_0 randomized. I just spent five minutes talking to you about causation and association so you should
spk_0 not be asking this question again in this manner because it's unlikely that you will find this
spk_0 type of answer that maybe when you have larger sample size you would know better because you will
spk_0 have more power but I will have my reservations on the conclusions because this is clear to me at
spk_0 this point. The multitude of these insular variables would have some sort of effect but them individually
spk_0 is unlikely unless there is something that we are systematically doing that would result in derailing
spk_0 the patient's outcomes and we are finding from select two and from prior studies that actually
spk_0 start the case with evidence. You bring up a number of good points there but importantly even if
spk_0 there is some selection bias as long as people are selecting based on their level of skill and comfort
spk_0 in reprefusing the brain it's a really strong message from the entire body of this work which is that
spk_0 the brain even in the setting of large ischemic core large strokes refusing that brain cures a lot
spk_0 of ills and washes out a lot of other ways that we try to optimize patient care and that's an
spk_0 important message to take away. It's really what you learned early in your residency and what you
spk_0 will continue to teach residents verbally until we get to a point that stroke is a plot in the blood
spk_0 vessel prevents low to the brain and the mainstay wise is and will always be reprefusion.
spk_0 Opening the blood vessel beats not opening the blood vessels eight days a week. The other variables
spk_0 important the nursing care the other things absolutely but spending resources just the messages
spk_0 go ahead and perfect what you do best and you will have good results better results than
spk_0 medical management in this population. Valid point and as you say I tell my residents the students
spk_0 all the time the brain doesn't care how it gets blood flow back as long as it happens and you do it
spk_0 as safely and quickly as possible that's a main message to make it which and all this ongoing
spk_0 richness data that come out of extent IA and now the select research trials what am I going to
spk_0 be interviewing you about on the podcast next what excites you most about to the next steps and
spk_0 it's always wonderful to be with you Andy and to look at the future so we have done a lot of
spk_0 analysis from select to it to be worth mentioning we are up to the 16th or the 17th daybar.
spk_0 If you important points to highlight we looked at one year outcomes and this was published in
spk_0 Lancet and patients continue to improve you have 20% of the patients who continue to improve
spk_0 between nine to days and one year very important that you are patient with your patients. Scott
spk_0 Castner published a very nice paper on Nellies and Hemicrania versus Noemicrania in early
spk_0 withdrawal of care and patients do worse when we think they will do worse so give the patients
spk_0 opportunity you don't expect patients who have a perfusion of very large core to be running
spk_0 down the whole way on day to rehabilitation works it may take longer and actually it opens the
spk_0 door is do we need to do longer than three months or outcomes up to one year no difference in
spk_0 hemicrania versus no hemicrania so don't be shy if you needed to do hemicrania for these patients
spk_0 and reliefing the pressure and giving them an opportunity no difference between men and women
spk_0 very important message the frailty and the woman of older age you may predict worse outcomes this
spk_0 was not the case close effectiveness in different healthcare system and that's important
spk_0 to the health care systems to adapt this in the United States in Europe and Australia
spk_0 different imaging modalities CT aspects perfusion which we mentioned originally no difference so
spk_0 this is refreshing that this became as well guidelines may take a little bit of time this became
spk_0 part of the practice you and I can't attest to that time many people already change their
spk_0 because they see the evidence so next is we a few things that we still need to understand and
spk_0 to optimize things the treatment benefit and this population what was driven by a reperfusion
spk_0 part of it decreasing final and viral in part of it what is the role of cerebral edema what is
spk_0 one plus two plus three equals percentage of the improvement may not be from a single trial may
spk_0 need the collected collective data and it's good to share with your audience that the PIs for
spk_0 all the doctor randomized trials met agreed a few months ago to proceed with a meta-analysis
spk_0 of this population to shed light on the subgroups because there's no single trials power to
spk_0 tell you is it beneficial more than 150 you have a higher limit what about the Erlund versus
spk_0 Slate wonder even the question that we've just discussed about anesthesia and blood pressure and
spk_0 all of that so this data will be presented in its first shape at the World Stroke Conference in
spk_0 Barcelona next month the Atlas meta-analysis and will be again reread all of the images by
spk_0 independent core lab with Dr. Campbell and in Melbourne and then we'll probably represent the data
spk_0 and publish it to shed light and look at all of these subgroups how can we optimize the patients how
spk_0 can we enhance the outcomes for this population to get patients because this is why research is
spk_0 done it's not just to answer my curiosity or yours is to bring the questions that will bring a new
spk_0 treatment to patients and new populations to get patients back to their family into the society
spk_0 sound healthy and probably productive part of the society I believe that you're also going to be
spk_0 looking at patients who present after 24 hours from last know that is still an area where there's
spk_0 some echo poise these patients that present very late from time of last know correct me if I'm
spk_0 wrong this will be the select late trial that we're hoping to get off the ground and learn some from
spk_0 so for a long time we invest in nature of human being operated on having a line in the sand for
spk_0 time patients with TBA first three hours and four and a half hours from back to me first six hours
spk_0 than 24 hours but what about the population that may present beyond 24 hours and might still have
spk_0 viable brain tissue to be treated we're looking at this in this elect late trial and hopefully
spk_0 we partner on this with you in the population in the University of Virginia currently this is
spk_0 another uncharted territory so size is done what about late what about time can we open the door
spk_0 for those patients who may present two days from their last well more than 24 hours and if this
spk_0 shown to be positive and we published the cohorts multi center international study about this
spk_0 and showed potential benefit so we're known randomizing the patients if these patients would
spk_0 benefit this would change a lot this would change our assistance of care approach transfer
spk_0 and patients all of that but it's all would be for the good of the patients and yeah this might be
spk_0 a few years away it's a grant from the patient center to outcome and I'm really happy to
spk_0 partner with you and other colleagues on this to bring an answer to this important question
spk_0 fantastic that's a great message to end on and certainly sounds like there's a lot of ongoing
spk_0 collaboration that will lead even better analysis from these collective data within that atlus
spk_0 consortia and I will be excited to hear about that and perhaps we will bring you back on to tell
spk_0 us about that once it's presented at world's shirt congress next month but in the meantime I want
spk_0 to think again my colleague Amru Saraj for joining us with the podcast is discuss this paper again
spk_0 titled general versus non-general anesthesia for end of asco thrombone that to me and patients with
spk_0 large core strokes a pre-sumissified secondary analysis of the select to trial seek out the
spk_0 main paper in the neurology journal and look forward to this and other podcasts on the topic and
spk_0 really thank you so much again for joining us this is tacy claudier podcast editor if you've enjoyed
spk_0 the podcast please take a few moments to subscribe rate and review the neurology podcast through apple
spk_0 podcasts google podcast spotify or wherever you listen and remember you can always head to neurology.org
spk_0 exlash podcast for a full list of past episodes where you can also search by keyword in your podcast
spk_0 app running neurology specific topics you want to learn about